Drug Trial Radar · NCT05658484
A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China
Last checked: Nov 20, 2026Latest source record: May 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Jun 9, 2023
Primary completion
Mar 27, 2025
Study completion Apr 12, 2025
Sponsor
- Lead sponsor
- BiogenBiogen (BIIB)
- Sponsor type
- Industry
- First posted
- Dec 20, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to assess the efficacy of DMF in Chinese participants with RMS at Week 48. The secondary objectives of the study are to assess the efficacy and safety of DMF in Chinese participants with RMS.
Conditions
- Multiple Sclerosis
Interventions
Dimethyl fumarateDrug
Administered as specified in the treatment arm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized Relapse Rate (ARR)Time frame: Week 48
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Beijing Hospital
Beijing, China
Xiangya Hospital Central South University
Changsha, China
West China Hospital of Sichuan University
Chengdu, China
The First Affiliated Hospital of Fujian Medical University
Fuzhou, China
The Third Affiliated Hospital of Sun Yat-Sen University
Guangzhou, China
The Second Hospital of Hebei Medical University
Hebei, China
The First People's Hospital of Yunnan Province
Kunming, China
Renji Hospital, Shanghai Jiatong Uni. School of Medicine
Shanghai, China
Huashan Hospital, Fudan University
Shanghai, China
The First Hospital of China Medical University
Shengyang, China
The First Affiliated Hospital of Soochow University
Suzhou, China
The First Affiliated Hospital of Shanxi Medical University
Taiyuan, China
Tianjin Medical University General Hospital
Tianjin, China
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, China
Second Affiliated Hospital of Air Force Medical University
Xi'an, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.